Latest News & Developments
Eurolab has achieved a landmark legal victory in South Africa, allowing the company to produce and sell a generic version of the prostate cancer medication enzalutamide, ensuring affordable access for patients
Eurolab has achieved a landmark legal victory in South Africa, allowing the company to produce and sell a generic version of the prostate cancer medication enzalutamide, ensuring affordable access for patients
Eurolab has achieved a landmark legal victory in South Africa, allowing the company to produce and sell a generic version of the prostate cancer medication enzalutamide, ensuring affordable access for patients
The matter arose after Eurolab identified the potential of enzalutamide, an inhibitor, used in the treatment of prostate cancer patients in South Africa.